Molecular Subtype

Chronic Myeloid Leukemia, BCR-ABL1 Positive

CI-CAN-00002365CMLExplore in graph →

Hematologic102 active trials3 approved drugs320 evidence items

NCIt: C3174
OncoTree: CMLBCRABL1
DOID: 0081088
DOID: 8552

UMLS CUI

C2861580

MeSH

D015464

Clinical trials

Registered studies

649 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 102
Recruiting: 49
Ph III recruiting: 2
Growth YoY: —
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (104)

No study matches these filters